SCHEMBL537022

SCHEMBL537022

CCCCCCCCCCCCC(O)C(O)COc1ccc(-c2nc(-c3ccc(C)cc3C)nc(-c3ccc(C)cc3C)n2)c(O)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 5/20 0.34
CNR1 P21554 2/20 0.34
NPC1 O15118 3/20 0.34
MAPK1 P28482 3/20 0.34
RAB9A P51151 2/20 0.34
TP53 P04637 2/20 0.34
NFKB1 P19838 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PLA2G4B P0C869 1/20 0.34
POLB P06746 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
TLR8 Q9NR97 1/20 0.34
ENPP2 Q13822 1/20 0.34
PLK1 P53350 2/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1552126 1.00 CNR2 (0.34) CNR2CNR1NPC1MAPK1RAB9A
SCHEMBL1552093 1.00 CNR2 (0.34) CNR2CNR1NPC1MAPK1RAB9A
SCHEMBL5563221 0.96 CNR2 (0.32) CNR2CNR1NPC1MAPK1RAB9A
SCHEMBL2511599 0.96 NPC1 (0.35) CNR2CNR1NPC1MAPK1RAB9A
SCHEMBL30847778 0.91 PLA2G4B (0.39) CNR2CNR1NPC1MAPK1RAB9A
SCHEMBL14480155 0.91 PLA2G4B (0.39) CNR2CNR1NPC1MAPK1RAB9A
SCHEMBL30310082 0.91 PLA2G4B (0.39) CNR2CNR1NPC1MAPK1RAB9A
SCHEMBL14480246 0.91 PLA2G4B (0.39) CNR2CNR1NPC1MAPK1RAB9A
SCHEMBL3700899 0.87 CNR2 (0.40) CNR2CNR1TP53PLA2G4BENPP2
SCHEMBL937883 0.87 CNR2 (0.40) CNR2CNR1TP53PLA2G4BENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2985325-A1 COMPOSITION FOR FORMING FAR-INFRARED RADIATION SHIELDING LAYER Fujifilm Corporation (JP) 2016-02-17 EP disclosed
US-20160033680-A1 COMPOSITION FOR FORMING FAR-INFRARED RADIATION SHIELDING LAYER FUJIFILM CORPORATION (JP) 2016-02-04 US disclosed
US-20120053283-A1 POLYMER ADDITIVES CONTAINING PARTICLES BASF SE (DE) 2012-03-01 US disclosed
EP-2418944-A2 METHOD FOR COMBATING HARMFUL FUNGI BASF SE (DE) 2012-02-22 EP disclosed
EP-2413691-A2 METHOD FOR REDUCING SUNBURN DAMAGE IN PLANTS BASF SE (DE) 2012-02-08 EP disclosed
WO-2010115721-A2 METHOD FOR REDUCING SUNBURN DAMAGE IN PLANTS BASF SE (DE) 2010-10-14 WO disclosed
WO-2010115720-A2 METHOD FOR COMBATING HARMFUL FUNGI BASF SE (DE) 2010-10-14 WO disclosed
US-20090318605-A1 POLYMER ADDITIVES CONTAINING PARTICLES BASF SE (DE) 2009-12-24 US disclosed
US-20080146448-A1 Aqueous Polymer Dispersions Comprising Effect Substances, Processes For Preparing Them And Their Use BASF AKTIENGESELLSCHAFT (DE) 2008-06-19 US disclosed
US-6899939-B2 Polymer mixtures BAYER AKTIENGESELLSCHAFT (DE) 2005-05-31 US disclosed
US-6803392-B1 AQUEOUS, STORAGE-STABLE, NON- SEDIMENTING SUSPENSIONS COMPRISING AT LEAST ONE MONO- OR BIS-ACYLPHOSPHINE OXIDE CIBA SPECIALTY CHEMICALS CORPORATION 2004-10-12 US disclosed
EP-1379583-A1 NOVEL POLYMER BLENDS Bayer Aktiengesellschaft (DE) 2004-01-14 EP disclosed
US-20030073779-A1 Aqueous dispersion and coated product JSR CORPORATION (JP) 2003-04-17 US disclosed
US-20020173566-A1 New polymer mixtures BAYER AKTIENGESELLSCHAFT (DE) 2002-11-21 US disclosed
EP-1256611-A2 Aqueous dispersion and coated product JSR Corporation (JP) 2002-11-13 EP disclosed
WO-2002077087-A1 NOVEL POLYMER BLENDS BAYER AKTIENGESELLSCHAFT (DE) 2002-10-03 WO disclosed
EP-1230276-A1 PHOTOINITIATOR FORMULATIONS Ciba SC Holding AG (CH) 2002-08-14 EP disclosed
WO-2001029093-A1 PHOTOINITIATOR FORMULATIONS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146448-A1 Aqueous Polymer Dispersions Comprising Effect Substances, Processes For Preparing Them And Their Use NOTUM, AUP1, PLOD2 CNR2 1477/4885CNR1 2153/4885NPC1 3755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.